Clinical study to check benefit of iCare plus in management of health during menopause period

Clinical study to evaluate effect of iCare plus in management of health during menopause period. A quality-of-life clinical study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070216

Enrollment

Registered

2024-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: iCare plus: Polyherbal liquid formula containing Emblica officinalis, Bosewellia serrata, Curcuma longa, Asparagus racemosus, Tribulus terrestris, Vitex negundo, Cissus quadrangularis,

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women aged over 40 2.Subjects going through menopause 3.Subjects who voluntarily agree to participate in this clinical trial in writing 4.Subjects who have more than 2 symptoms according to menopause care QOL

Exclusion criteria

Exclusion criteria: 1.Subjects with hysterectomy or oophorectomy 2.PCOD or similar condition 3.Subjects who are on steroids for certain health conditions 4.Subjects who refuse to sign the informed consent form.

Design outcomes

Primary

Measure	Time frame
Changes in Menopause Rating scale, hot flushes, night sweats, anxiety, stress, joint pain and other symptoms of menopauseTimepoint: baseline, 3rd month and 6th month.	—

Secondary

Measure	Time frame
changes in lab values for estrogen, FSH and LH. Also, safety of IPTimepoint: baseline, 3rd month and 6th month.	—

Countries

India

Contacts

Public ContactDr Hema Divakar

Divakars Speciality Hospital

divakargv@gmail.com9900154448

Outcome results